Drug industry groups target Hims & Hers Super Bowl ad touting weight loss drug
Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.
Time on MSN7d
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Verywell Health on MSN4d
A New 'Missile' Drug Is Approved To Treat the Most Common Breast Cancer Type
The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...
Yale Daily News5d
First FDA-approved non-addictive painkiller has Yale roots
Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
Verywell Health on MSN10d
New FDA-Approved Painkiller Is a Safer Alternative to Opioids
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with ...
Historic FDA approval marks first nonopioid breakthrough since Clinton era
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
Nature11d
US drug agency approves potent painkiller — the first non-opioid in decades
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
CNN on MSN13d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
BECAUSE THESE MEDICATIONS TARGET INFLAMMATION ... for an average of about 3½ years.The new indications, approved Tuesday by ...
Yahoo Finance25d
FDA beats EMA to most approved new drugs in 2024
The FDA approved 50 novel drugs that contained an active ingredient ... Both treatments are monoclonal antibodies that target beta plaques in the brain, though Kisunla is infused every four ...
People12d
FDA Approves Ozempic to Treat Kidney Disease
The FDA’s new approval makes the drug the first GLP-1 treatment option ... So if you have a medicine that can target each of these co-morbidities in one injection, then you’re addressing ...
Time11d
FDA Approves the First Non-Opioid Pain Drug in 20 Years
On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine ... Finding the right sodium channel target, however, took decades of research, which was all the ...